Replies to post #71432 on PCT Ltd (PCTL)

[Egold]

I'm sure there all over that Steve.

This is not a setback nor going to change anything

Why

Because have a deal with the UK right around the corner. I believe 4 hospitals to start and Gary said upward of 600. That's major dollars.

Pctl has distribution in place for service of the units through Ace and distribution channels that will come onboard in the future

PCTL has relationships already set in place with some of the most prestigious hospitals in the country. New hospitals are calling them now

PCTL is in great shape.

[beer$$money]

Agreed 100% and glad you dived into that DD as deep as you did. You were correct and It should get resolved. Until then PCTL is the "only" company with the complete solution "World Wide"

[FatCatFenix]

PCTHealth was always for Annihilyzer, only recently its changed to Annihilare so they must be aware. As they migrated to PCTCorpHeatlh.

Way back machine, to go back in time on websites.
https://web.archive.org/web/2019*/Pcthealth.com

There must be some patent sharing going on, I remember reading something about a 3 year exclusivity way way back when going through the patent purchases that had been negotiated, going from memory I’m sure someone will have a blast looking that one up. I believe Annihilare is also being used on some planes, again just from memory.

[Long term]

The key is to get the government to become aware of what our product can do...check this site out.

https://www.medicalcountermeasures.gov/Request-BARDA-TechWatch-Meeting/

point of entry for the submission of market research packages and meeting requests from interested stakeholders.
The U.S. government, in response to the COVID-19 outbreak, seeks information from stakeholders on available medical countermeasures in development. We are particularly interested in products and technologies that have progressed into or beyond non-clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform. Information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing this outbreak are sought.
At this time, we ask for a brief description of your product or technology, accompanied by a slide deck, manuscript, publications, or other non-confidential information of your choosing. Please note that while we will use any information you present as market research, submission is no guarantee of a meeting or funding and your submission will be shared across U.S. Government agencies involved in COVID-19 medical countermeasure research and development.  Only U.S. government officials are invited to join a CoronaWatch meeting, and are bound by law to maintain confidentiality of what is presented and discussed.
Ideal technologies and products would (but are not required to) be:
* - Relevant to the U.S. government COVID-19 medical countermeasure research and development efforts and/or Emerging Infectious Disease rapid response capabilities
* - Utilize an already-approved platform, have non-clinical data suggesting efficacy, and/or have significant manufacturing capability
* - Fully owned or licensed by your organization (you have full IP rights and/or freedom to operate)
 
Would you like to meet with a federal agency regarding a product that you are developing for COVID-19?
If you are interested in requesting a CoronaWatch meeting, please Register for an account and Login, or if you have an account Login to submit some basic product information.